VANDETANIB
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | INHIBITOR | Tyrosine-protein kinase SRC inhibitor | no | 4 | 2 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Small molecule | INHIBITOR | Tyrosine-protein kinase SRC inhibitor | no | 4 | 2 |